Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
Introduction: The aim of this study was to compare the effect of ramipril/canrenone versus ramipril/hydrochlorothiazide (HCTZ) combination on atrial fibrillation (AF) recurrence in type 2 diabetic hypertensives with and without cardiac autonomic neuropathy (CAN). Material and methods : A total o...
Main Authors: | Daniele Bosone, Alfredo Costa, Natascia Ghiotto, Matteo Cotta Ramusino, Annalisa Zoppi, Angela D’Angelo, Roberto Fogari |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-09-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.termedia.pl/Effect-of-ramipril-hydrochlorothiazide-and-ramipril-canrenone-combination-on-atrial-fibrillation-recurrence-in-hypertensive-type-2-diabetic-patients-with-and-without-cardiac-autonomic-neuropathy,19,28358,1,1.html |
Similar Items
-
Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial)
by: Rafał Dąbrowski, et al.
Published: (2020-05-01) -
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
by: Derosa G, et al.
Published: (2018-08-01) -
Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
by: I. E. Chazova, et al.
Published: (2010-08-01) -
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients
by: Guasti L, et al.
Published: (2017-08-01) -
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
by: Marco Vicenzi, et al.
Published: (2020-09-01)